SCHEMBL8669762

SCHEMBL8669762

NCC(CN)CCN1C(=O)c2cccc3c([N+](=O)[O-])ccc(c23)C1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 14/20 0.61
▸ KMT2A Q03164 14/20 0.61
▸ POLB P06746 7/20 0.61
▸ NPSR1 Q6W5P4 5/20 0.61
▸ SMN1; SMN2 Q16637 4/20 0.61
▸ CCR6 P51684 3/20 0.61
▸ LMNA P02545 3/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ PABPC1 P11940 2/20 0.61
▸ RAB9A P51151 5/20 0.58
▸ NPC1 O15118 7/20 0.57
▸ HDAC3 O15379 1/20 0.56
▸ HDAC1 Q13547 1/20 0.56
▸ HDAC11 Q96DB2 1/20 0.56
▸ HDAC8 Q9BY41 1/20 0.56
▸ HDAC6 Q9UBN7 1/20 0.56
▸ NCOR2 Q9Y618 1/20 0.56
▸ MAPT P10636 6/20 0.54
▸ HTT P42858 5/20 0.54
▸ L3MBTL1 Q9Y468 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8669764 0.87 MEN1 (0.60) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL14067864 0.86 MEN1 (0.68) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL10261656 0.81 MEN1 (0.68) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL29903439 0.81 MEN1 (0.68) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL8672550 0.80 MEN1 (0.56) MEN1KMT2APOLBLMNAALDH1A1
SCHEMBL8664259 0.80 KDM4E (0.60) MEN1KMT2APOLBLMNAALDH1A1
SCHEMBL14560563 0.79 MEN1 (0.76) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL10018568 0.78 MEN1 (0.68) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL10018577 0.78 RAB9A (0.70) MEN1KMT2APOLBNPSR1SMN1; SMN2
SCHEMBL3759222 0.78 MEN1 (0.86) MEN1KMT2APOLBNPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5789418-A Bis-naphthalimides for the treatment of cancer BASF AKTIENGESELLSCHAFT (DE) 1998-08-04 — — US disclosed
Send feedback